Paul Tudor Jones's AVNS Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 71,893 shares of Avanos Medical, Inc. (AVNS) worth $831,083, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in AVNS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 60,099 shares. Largest reduction occurred in Q2 2024, reducing 45,094 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Avanos Medical (AVNS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avanos Medical (AVNS) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2020 | +9,637 | New Buy | 9,637 | $26.98 |
| Q2 2020 | +15,728 | Add 163.20% | 25,365 | $29.37 |
| Q3 2020 | -13,797 | Reduce 54.39% | 11,568 | $33.20 |
| Q4 2020 | -11,568 | Sold Out | 11,568 | $0.00 |
| Q2 2021 | +20,786 | New Buy | 20,786 | $36.37 |
| Q3 2021 | -20,786 | Sold Out | 20,786 | $0.00 |
| Q4 2021 | +14,288 | New Buy | 14,288 | $34.64 |
| Q1 2022 | +18,890 | Add 132.21% | 33,178 | $33.49 |
| Q2 2022 | -5,463 | Reduce 16.47% | 27,715 | $27.35 |
| Q3 2022 | +38,819 | Add 140.06% | 66,534 | $21.78 |
| Q4 2022 | -14,272 | Reduce 21.45% | 52,262 | $0.03 |
| Q1 2023 | -52,262 | Sold Out | 52,262 | $0.00 |
| Q3 2023 | +22,030 | New Buy | 22,030 | $20.22 |
| Q4 2023 | -22,030 | Sold Out | 22,030 | $0.00 |
| Q1 2024 | +75,856 | New Buy | 75,856 | $19.91 |
| Q2 2024 | -45,094 | Reduce 59.45% | 30,762 | $19.92 |
| Q3 2024 | -30,762 | Sold Out | 30,762 | $0.00 |
| Q4 2024 | +32,571 | New Buy | 32,571 | $15.92 |
| Q1 2025 | +15,710 | Add 48.23% | 48,281 | $14.33 |
| Q2 2025 | -36,487 | Reduce 75.57% | 11,794 | $12.24 |
| Q3 2025 | +60,099 | Add 509.57% | 71,893 | $11.56 |
Paul Tudor Jones's Avanos Medical Investment FAQs
Paul Tudor Jones first purchased Avanos Medical, Inc. (AVNS) in Q1 2020, acquiring 9,637 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Avanos Medical, Inc. (AVNS) for 23 quarters since Q1 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Avanos Medical, Inc. (AVNS) was in Q1 2024, adding 75,856 shares worth $1.51 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 71,893 shares of Avanos Medical, Inc. (AVNS), valued at approximately $831,083. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Avanos Medical, Inc. (AVNS) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Avanos Medical, Inc. (AVNS) was 75,856 shares, as reported at the end of Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.